Novartis

Isomorphic inks deals with Eli Lilly and Novartis for drug discovery

Isomorphic Labs, the London-based, drug discovery–focused spinout of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical

African genomics startup 54gene raises $15M led by Adjuvant Capital

Greater availability of African genomic data could lead to medical breakthroughs for the continent’s 1.2 billion people. That’s the driving proposition of 54gene — a U.S. and Nigeria-bas

PathAI raises $60 million for its computer vision-based pathology detection technology

With a clinical version of PathAI‘s computer vision-based pathology detection service still at least one year from coming to market, the diagnostic technology developer has snagged $60 million i

uBiome is jumping into therapeutics with a healthy $83 million in Series C financing

23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether you

The top 10 startups from Y Combinator’s Demo Day S18 Day 2

Fifty-nine startups took the stage at Y Combinator’s Demo Day 2, and among the highlights were a company that helps developers manage in-app subscriptions; a service that lets you create animoji

1 week until the deadline for Disrupt SF 2018’s Hackathon + new sponsor prizes

Are you a hacking speed demon of incomparable skill? Then we want you to submit your best hack to the Virtual Hackathon going down at TechCrunch Disrupt San Francisco 2018 on September 5-7. But you ne

The biotech empires of Silicon Valley and Europe

Bérénice Magistretti Contributor Bérénice Magistretti is a Swiss freelance writer based in San Francisco. She focuses on startups in Saudi Arabia, Switzerland and emerging markets. More posts by t

Google Enlists Novartis To Ship Glucose-Sensing And Autofocus Smart Contact Lenses In As Little As 5 Years

Google has announced a new licensing deal with big pharmacy corporation Novartis to bring its “smart” contact lenses, with the power to help diabetics track their blood glucose level, to p